Alexander G.C.,Emerson S.,Kesselheim A.S. .2021 .Evaluation of aducanumab for Alzheimer disease: Scientific evidence and regulatory review involving eficacy, safety, and futility. J. Am. Med, 325 : 1717-1718.
.2023 .. December, 13 : 2967.
Dubois B.,Hampel H.,Feldman H.H.,Scheltens P.,Aisen P.,Andrieu S.,Bakardjian H.,Benali H.,Bertram L.,Blennow K. .2016 .Preclinical alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's Dement, 02 : 292-323.
Eissa D.M.,Mabrouk M.M.,Ebeid E.Z.M.,Hamid A.M.A. .2022 .Hydrophilic gold nanospheres: Influence of alendronate, memantine, and tobramycin on morphostructural features. BMC Chem, 16 : 1-15.
Ella F.A.,Fewou S.N.,Koloko M.R.D.,Owona P.,Njayou F.N.,Moundipa P.F. .2022 .Khaya grandifololia improves cognition and prevents scopolamine-induced impairment of brain functions by activating the cholinergic and antioxidant systems in rats. Am. J. Biomed. Life Sci, 20221003 : 84-96.
Filardi M.,Barone R.,Bramato G.,Nigro S.,Tafuri B.,Frisullo M.E.,Zecca C.,Tortelli R.,G. R. .2022 .The relationship between muscle strength and cognitive performance across Alzheimer's disease clinical continuum. Front, 13 : 833087.
Folch J.,Busquets O.,Ettcheto M.,Sánchez-López E.,Castro-Torres R.D.,Verdaguer E.,Garcia M.L.,Olloquequi J.,Casadesús G.,BeasZarate C. .2018 .Memantine for the treatment of dementia: A review on its current and future applications. J. Alzheimer's Dis, 62 : 1223-1240.
Gkintoni E.,Halkiopoulos C.,Antonopoulou C. .2022 .Neuroleadership an asset in educational settings: An overview. -06-04-016, 6 : 893-904.
Hamedi A.,Zengin G.,Aktumsek A.,Selamoglu Z.,Pasdaran A. .2020 .In vitro and in silico approach to determine neuroprotective properties of iridoid glycosides from aerial parts of Scrophularia amplexicaulis by investigating their cholinesterase inhibition and anti-oxidant activities. Bioint. Res. Appl. Chem, 10 : 5429-5454.
Hampel H.,Mesulam M.M.,Cuello A.C.,Farlow M.R.,Giacobini E.,Grossberg G.T.,Khachaturian A.S.,Vergallo A.,Cavedo E.,Snyder P.J. .2018 .hTe cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain, 141 : 1917-1933.
Heilman K.M.,Nadeau S.E. .2022 .Emotional and neuropsychiatric disorders associated with Alzheimer's disease. Neurotherapeutics, 19 : 99-116.
Jeong J.H.,Choi B.Y.,Kho A.R.,Lee S.H.,Hong D.K.,Lee S.H.,Lee S.Y.,Song H.K.,Choi H.C.,Suh S.W. .2017 .Diverse efects of an acetylcholinesterase inhibitor, donepezil, on hippocampal neuronal death after pilocarpineinduced seizure. Int. J. Mol. Sci, 18 : 2311.
Ji D.,Dai J.,Xu M.,Harris P.W.R.,Brimble M.A.,Agyei D. .2022 .Anticholinesterase inhibition, drug-likeness assessment, and molecular docking evaluation of milk protein-derived opioid peptides for the control of Alzheimer's disease. Dairy, 3 : 422-437.
Kanekiyo T.,Xu H.,Bu G. .2014 .ApoE and Aβ in Alzheimer's disease: Accidental encounters or partners?. Neuron, 01 : 740-754.
Khoury R.,Rajamanickam J.,Grossberg J. .2018 .An update on the safety of current therapies for Alzheimer's disease: Focus on rivastigmine. hTer. Adv. Drug Saf., 9 : 171-178.
Konishi K.,Hori K.,Tani M.,Tomioka H.,Kitajima Y.,Akashi N.,Inamoto A.,Kurosawa K.,Yuda H.,Hanashi T. .2015 .Hypothesis of endogenous anticholinergic activity in Alzheimer's disease. Neurodegener. Dis., 15 : 149-156.
Kumar A.,Sidhu J.,Goyal A.,Tsao J.W.,Doerr C. .2021 .Alzheimer disease (nursing).. , : .
Liu J.,Chang L.,Song Y.,Li H.,Wu Y. .2019 .The role of NMDA receptors in Alzheimer's disease. Front. Neurosci., 13 : 43.
Livingston G.,Huntley J.,Sommerlad A.,Ames D.,Ballard C.,Banerjee S.,Brayne C.,Burns A.,Cohen-Mansfield J.,Cooper C. .2020 .. 2020 report of the Lancet Commission. Lancet, 6736(20) : 30367-6.
Lleó A.,Núñez-Llaves R.,Alcolea D.,Chiva C.,Balateu-Paños D.,Colom-Cadena M.,GomezGiro M.,Muñoz L.,Querol-Vilaseca M.,Pegueroles J. .2019 .Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid. RA118.001290, 18 : 546-560.
Lopez-Arrieta Q.N.B.J. .2000 .Jlewington Sszeto Stacrine for Alzheimer's disease. Cochrane Datab. Syst. Rev., 2 : .
Maccioni R.B.,Farías G.,Morales I.,Navarrete L. .2010 .The revitalized tau hypothesis on Alzheimer's disease. Arch. Med. Res., 03 : 226-231.
Medina M. .2018 .An overview on the clinical development of tau-based therapeutics. Int. J. Mol. Sci, 19 : 1160.
Mudher A.,Lovestone S. .2002 .Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci. , 2236(00) : 02031-2.
Organization W.H. .2023 .Multiregional workshop on the implementation of the global action plan on public health response to dementia. , 29 : 302-303.
Paroni G.,Bisceglia P.,Seripa D. .2019 .Understanding the amyloid hypothesis in Alzheimer's disease. J. Alzheimer's Dis, 68 : 493-510.
Ramirez-Bermudez J. .2012 .Alzheimer's disease: Critical notes on the history of a medical concept. Arch. Med. Res., 11 : 595-599.
Sano M.,Cummings J.,Auer S.,Bergh S.,Fischer C.E.,Gerritsen D.,Grossberg G.,Ismail Z.,Lanctôt K.,Lapid M.I. .2023 .Agitation in cognitive disorders: Progress in the international psychogeriatric association consensus clinical and research definition. Int. Psychogeriatr., : 1-13.
Savelie f M.G.,Lee S.,Lim Y.,M.H. Y. .2013 .Untangling amyloid-β, tau, and metals in Alzheimer's disease. ACS Chem. Biol, 8 : 856-865.
Scheltens P.,De Strooper B.,Kivipelto M.,Holstege H.,Chételat G.,Teunissen C.E.,Cummings C.E.,van der Flier C.E. .2021 .Alzheimer's disease. Lancet, 6736(20) : 32205-4.
Selamoglu-Talas Z.,Ozdemir I.,Ciftci O.,Cakir O. .2013 .Propolis attenuates oxidative injury in brain and lung of nitric oxide synthase inhibited rats. J. Pharm. Care, : 45-50.
Serrano-Pozo A.,Frosch M.P.,Masliah E.,Hyman B.T. .2011 .Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med, 1 : .
Shakir M.N.,Dugger B.N. .2022 .Advances in deep neuropathological phenotyping of Alzheimer disease: Past, present, and future. J. Neuropathol. Exp. Neurol., 81 : 2-15.
Shan G. .2022 .Monte Carlo cross-validation for a study with binary outcome and limited sample size. BMC Med, 22 : 1-15.
Shi Q.,Xiong X.,Wen Z.,Qin C.,Li R.,Gong Z.,Wu Q.,X. Q. .2022 .Cu/Zn superoxide dismutase and catalase of Yangtze sturgeon, Acipenser dabryanus: Molecular cloning, tissue distribution and response to fasting and refeeding. Fishes, 7 : 35.
Singh A.,Kukal S.,Kanojia N.,Singh M.,Saso L.,Kukreti S.,Kukreti R. .2023 .Lipid mediated brain disorders: A perspective. , : 106737.
Singh S.K.,Srivastav S.,Yadav A.K.,Srikrishna S.,Perry G. .2016 .Overview of Alzheimer's disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds. Oxid. Med, : .
Singh T.A.,Das J.,Sil P.C. .2020 .Zinc oxide nanoparticles: A comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks. Adv. Colloid Interface Sci, 286 : 102317.
Spires-Jones T.L.,Hyman B.T. .2014 .The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron, 05 : 756-771.
Srivastava S.,Rathore H.,Tiwari K. .2023 .Cognitive-inspired episodic memory in deep Q-Networks. , : 1-6.
Tabaton M.,Piccini A. .2005 .Role of water-soluble amyloid-β in the pathogenesis of Alzheimer's disease. Int. J. Exp. Pathol., 00428 : 9673-145.
Tata M.A.,Velluto L.,D'Angelo C.,Reale M. .2014 .Cholinergic system dysfunction and neurodegenerative diseases: Cause or efect? CNS Neurol. Disord. Targets (Formerly Curr. Drug TargetsCNS Neurol. , 13 : 1294-1303.
Tarawneh R.,D R.,Crimmins G.,Herries D.,Griest E.,Fagan T.,Zipfel A.M.,Ladenson G.J.,Morris J.H.,Holtzman J.C.,D.M. J.C. .2016 .Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease. JAMA Neurol, 73 : 561-571.
hTal D.R.,Tomé S.O. .2022 .The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death. Brain Res. Bull, 10 : .
hTeisler C. .2022 .Adjuvant medical care. , : .
Varzaghani V.,Sharifi M.,Hajiaghaee R.,Bagheri S.,Momtaz S.,Tarassoli Z.,Razmi A. .2022 .Propolis add-on therapy alleviates depressive symptoms; A randomized placebo-controlled clinical trial. Phyther. Res., 36 : 1258-1267.
Viktorinova A.,Durfinova M. .2021 .Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?. Neurosci. Lett., 745 : 135627.
Vos S.J.B.,Verhey F.,Frölich L.,Kornhuber J.,Wiltfang J.,Maier W.,Peters O.,Rüther E.,Nobili F.,Morbelli S. .2015 .Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain, 138 : 1327-1338.
Wahba S.M.R.,Darwish A.S.,Kamal S.M. .2016 .Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model. Mater. Sci. Eng, 04 : 151-163.
Wattmo C.,Minthon L.,Wallin L. .2016 .Mild versus moderate stages of Alzheimer's disease: hTree-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers. Res. hTer., 8 : 1-15.
Zhu X.,Zhang Y.,Yang X.,Hao C.,Duan C. .2021 .Gene therapy for neurodegenerative disease: Clinical potential and directions. Front. Mol. Neurosci., 14 : 618171.